# A Study to Compare Omeprazole Administered as Zegerid® Powder and as Prilosec® Capsule in Healthy Participants (P08050)(CL2010-12)

> **NCT01337804** · PHASE1 · COMPLETED · sponsor: **Bayer** · enrollment: 50 (actual)

## Conditions studied

- Heartburn

## Interventions

- **DRUG:** omeprazole/sodium bicarbonate
- **DRUG:** omeprazole magnesium

## Key facts

- **NCT ID:** NCT01337804
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2015-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01337804

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01337804, "A Study to Compare Omeprazole Administered as Zegerid® Powder and as Prilosec® Capsule in Healthy Participants (P08050)(CL2010-12)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01337804. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*